Continuous renal replacement therapy in the treatment of acute renal failure: Criticai assessment is required

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 2, 2007, Pages 385-389

  Himmelfarb, Jonathan ^a  

^a MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; HUMAN; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; REVIEW;

HUMANS; KIDNEY FAILURE, ACUTE; RANDOMIZED CONTROLLED TRIALS; RENAL REPLACEMENT THERAPY;

EID: 34548842506     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02890806     Document Type: Article

References (35)

1. Schrier RW, Wang W, Poole B, Mitra A: Acute renal failure: Definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114: 5-14, 2004
2. Bywaters EG, Delory GE, Rimington C, Smiles J: Myohaemoglobin in the urine of air raid casualties with crushing injury. Biochem J 35: 1164-1168, 1941
3. Teschan PE, Post RS, Smith LH Jr, Bernathy RS, Davis JH, Gray DM, Howard JM, Johnson KE, Klopp E, Mundy RL, O'Meara MP, Rush BF Jr: Post-traumatic renal insufficiency in military casualties. I. Clinical characteristics. Am J Med 18: 172-186, 1955
4. Smith LH Jr, Post RS, Teschan PE, Bernathy RS, Davis JH, Gray DM, Howard JM, Johnson KS, Klopp E, Mundy RL, O'Meara MP, Rush BF Jr: Post-traumatic renal insufficiency in military casualties. II. Management, use of an artificial kidney, prognosis. Am J Med 18: 187-198, 1955
5. Sever MS, Vanholder R, Lameire N: Management of crush-related injuries after disasters. N Engl J Med 354: 1052-1063, 2006
6. Chertow GM, Soroko SH, Paganini EP, Cho KC, Himmelfarb J, Ikizler TA, Mehta RL: Mortality after acute renal failure: Models for prognostic stratification and risk adjustment. Kidney Int 70: 1120-1126, 2006
7. Conger JD, Robinette JB, Schrier RW: Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. J Clin Invest 82: 532-537, 1988
8. Solez K, Morel-Maroger L, Sraer JD: The morphology of "acute tubular necrosis" in man: Analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine (Baltimore) 58: 362-376, 1979
9. Kramer P, Wigger W, Rieger J, Matthaei D, Scheler F: Arteriovenous haemofiltrafion: A new and simple method for treatment of over-hydrated patients resistant to diuretics [in German]. Klin Wochenschr 55: 1121-1122, 1977
10. Bellomo R, Ronco C: Continuous renal replacement therapy in the intensive care unit. Intensive Care Med 25: 781-789, 1999
11. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C: Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 294: 813-818, 2005
12. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, Zeeuw D, Hostetter TH, Lameire N, Eknoyan G: Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67: 2089-2100, 2005
13. Tonelli M, Manns B, Feller-Kopman D: Acute renal failure in the intensive care unit: A systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 40: 875-885, 2002
14. Mehta RL, McDonald B, Gabbai FB, Pahl M, Pascual MT, Farkas A, Kaplan RM: A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 60: 1154-1163, 2001
15. Uehlinger DE, Jakob SM, Ferrari P, Eichelberger M, Huynh-Do U, Marti HP, Mohaupt MG, Vogt B, Rothen HU, Regli B, Takala J, Frey FJ: Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant 20: 1630-1637, 2005
16. Vinsonneau C, Camus C, Combes A, Costa de Beauregard MA, Klouche K, Boulain T, Pallot JL, Chiche JD, Taupin P, Landais P, Dhainaut JF: Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 368: 379-385, 2006
17. Himmelfarb J, Tolkoff RN, Chandran P, Parker RA, Wingard RL, Hakim R: A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis. J Am Soc Nephrol 9: 257-266, 1998
18. Cho KC, Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, Mehta RL, Chertow GM: Survival by dialysis modality in critically ill patients with acute kidney injury. J Am Soc Nephrol 17: 3132-3138, 2006
19. Misset B, Timsit JF, Chevret S, Renaud B, Tamion F, Carlet J: A randomized cross-over comparison of the hemodynamic response to intermittent hemodialysis and continuous hemofiltration in ICU patients with acute renal failure. Intensive Care Med 22: 742-746, 1996
20. Schortgen F, Soubrier N, Delclaux C, Thuong M, Girou E, Brun-Buisson C, Lemaire F, Brochard L: Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: Usefulness of practice guidelines. Am J Respir Crit Care Med 162: 197-202, 2000
21. Schultz DG: FDA Updated Public Health Notification: Gambro Prisma(R) Continuous Renal Replacement System. Available at: http://www.fda.gov/ cdrh/safety/022706-gambro.html. Accessed September 22, 2006
22. Shure D: Pulmonary-artery catheters: Peace at last? N Engl J Med 354: 2273-2274, 2006
23. Swan HJ, Ganz W, Forrester J, Marcus H, Diamond G, Chonette D: Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med 283: 447-451, 1970
24. Robin ED: The cult of the Swan-Ganz catheter. Overuse and abuse of pulmonary flow catheters. Ann Intern Med 103: 445-449, 1985
25. Connors AF Jr, Speroff T, Dawson NV, Thomas C, Harrell FE Jr, Wagner D, Desbiens N, Goldman L, Wu AW, Califf RM, Fulkerson WJ Jr, Vidaillet H, Broste S, Bellamy P, Lynn J, Knaus WA: The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 276: 889-897, 1996
26. Wheeler AP, Bernard GR, Thompson BT, Schoenfeld D, Wiedemann HP, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL: Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 354: 2213-2224, 2006
27. Binanay C, Califf RM, Hasselblad V, O'Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW: Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial. JAMA 294: 1625-1633, 2005
28. Sandham JD, Hull RD, Brant RF, Knox L, Pineo GF, Doig CJ, Laporta DP, Viner S, Passerini L, Devitt H, Kirby A, Jacka M: A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 348: 5-14, 2003
29. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340: 409-417, 1999
30. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL: Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324: 781-788, 1991
31. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ: Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343: 1520-1528, 2000
32. Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA: Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352: 1092-1102, 2005
33. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M: Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 352: 1071-1080, 2005
34. Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, Boyce SW, Verburg KM: Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 352: 1081-1091, 2005
35. Cohn JN, Goldstein SO, Greenberg BH, Lorell BH, Bourge RC, Jaski BE, Gottlieb SO, McGrew F 3rd, DeMets DL, White BG: A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. N Engl J Med 339: 1810-1816, 1998